| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.16(B) |
| Last
Volume: |
762,316 |
Avg
Vol: |
474,459 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
3 |
6 |
6 |
8 |
| Total Sell Transactions |
5 |
11 |
16 |
28 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Foster James C |
Chairman, President and CEO |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$320,422 |
D/D |
(1,311) |
213,711 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$54,503 |
D/D |
(223) |
21,161 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$53,281 |
D/D |
(218) |
35,756 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$46,438 |
D/D |
(190) |
10,959 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2022-05-29 |
4 |
D |
$244.41 |
$13,198 |
D/D |
(54) |
6,438 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$27,374 |
D/D |
(112) |
4,396 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$30,551 |
D/D |
(125) |
21,384 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$36,662 |
D/D |
(150) |
35,974 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$27,863 |
D/D |
(114) |
11,149 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2022-05-28 |
4 |
D |
$244.41 |
$9,043 |
D/D |
(37) |
6,492 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
4,508 |
|
- |
|
| Pease Flavia |
Corporate Executive VP & CFO |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,637 |
6,822 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,657 |
21,509 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,455 |
36,124 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,493 |
11,263 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2022-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
491 |
6,529 |
|
- |
|
| Llado George |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
867 |
1,820 |
|
- |
|
| Massaro George |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
5,252 |
|
- |
|
| Kochevar Deborah Turner |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
6,671 |
|
- |
|
| Mackay Martin |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
841 |
10,503 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
18,614 |
|
- |
|
| Wilson Virginia M |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
2,742 |
|
- |
|
| Reese C Richard |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
957 |
64,435 |
|
- |
|
| Andrews Nancy C |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
575 |
1,795 |
|
- |
|
| Bertolini Robert J |
Director |
• • – |
2022-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
980 |
30,717 |
|
- |
|
2062 Records found
|
|
Page 9 of 83 |
|
|
1.28 (0.61%) 
